Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.53 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.53 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.34 |
| ▸ | CTSC | P53634 | 1/20 | 0.34 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL40622 | 1.00 | CYP1A2 (0.53) | CYP1A2ALOX15GRM2GRM3CYP2D6 | |
| SCHEMBL3145095 | 1.00 | CYP1A2 (0.53) | CYP1A2ALOX15GRM2GRM3CYP2D6 | |
| Hydrochloric Acid SCHEMBL1269592 | 0.98 | CYP1A2 (0.52) | CYP1A2ALOX15GRM2GRM3CYP2D6 | |
| Hydrochloric Acid SCHEMBL1269590 | 0.98 | CYP1A2 (0.52) | CYP1A2ALOX15GRM2GRM3CYP2D6 | |
| Chloromethane SCHEMBL22092026 | 0.94 | CYP1A2 (0.48) | CYP1A2ALOX15GRM2GRM3CYP2D6 | |
| Trifluoroacetic Acid SCHEMBL17924705 | 0.90 | CYP1A2 (0.46) | CYP1A2ALOX15GRM2GRM3CYP2D6 | |
| SCHEMBL6046221 | 0.84 | CYP1A2 (0.42) | CYP1A2ALOX15GRM2GRM3CYP2D6 | |
| SCHEMBL24576135 | 0.80 | GRM2 (0.34) | CYP1A2ALOX15GRM2GRM3CTSC | |
| SCHEMBL8289298 | 0.80 | GRM2 (0.34) | CYP1A2ALOX15GRM2GRM3CTSC | |
| SCHEMBL3666260 | 0.80 | GRM2 (0.38) | CYP1A2ALOX15GRM2GRM3CTSC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 795 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260077073-A1 | GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR)-TARGETED COMPOUNDS AND USES THEREOF | ALPHA 9 ONCOLOGY INC (CA) | 2026-03-19 | — | — | US | claimed |
| US-20250325672-A1 | ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS | BICYCLE TX LTD (GB) | 2025-10-23 | — | — | US | claimed |
| CN-119409613-B | Synthesis method of (S) - [2- (2-cyano-4, 4-difluoro-pyrrolidin-1-yl) -2-oxo-ethyl ] carbamic acid tert-butyl ester | 南京恒远科技开发有限公司 | 2025-04-11 | — | — | CN | claimed |
| WO-2025054727-A1 | RADIOLABELED COMPOUNDS FOR IN VIVO IMAGING OF GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) AND TREATMENT OF GRPR-RELATED DISORDERS | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2025-03-20 | — | — | WO | claimed |
| CN-119409613-A | Synthesis method of (S) - [2- (2-cyano-4, 4-difluoro-pyrrolidin-1-yl) -2-oxo-ethyl ] carbamic acid tert-butyl ester | 南京恒远科技开发有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-119158034-A | Bicyclic peptide ligands specific for conjugated protein-4 | 拜斯科技术开发有限公司 | 2024-12-20 | — | — | CN | claimed |
| EP-4464715-A2 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4 | BicycleTx Limited (GB) | 2024-11-20 | — | — | EP | claimed |
| EP-4450079-A1 | COMPOSITION FOR TREATING MACULAR DEGENERATION COMPRISING NOVEL PEPTIDE | EyebioKorea, Inc. (KR) | 2024-10-23 | — | — | EP | claimed |
| US-11904020-B2 | Bicyclic peptide ligands specific for TREM2 | BICYCLETX LIMITED (GB) | 2024-02-20 | — | — | US | claimed |
| EP-4308586-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TREM2 | BicycleTX Limited (GB) | 2024-01-24 | — | — | EP | claimed |
| WO-2015191705-A1 | NON-CANONICAL INSULINS AND THEIR USES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-12-17 | — | — | WO | claimed |
| US-20150353619-A1 | Non-Canonical Insulins and Their Uses | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2015-12-10 | — | — | US | claimed |
| US-8841257-B2 | Inhibitors of STAT3 and uses thereof | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-09-23 | — | — | US | claimed |
| US-20120035114-A1 | INHIBITORS OF STAT3 AND USES THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-02-09 | — | — | US | claimed |
| WO-2010118309-A2 | INHIBITORS OF STAT3 AND USES THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-10-14 | — | — | WO | claimed |
| EP-1007568-A1 | COLLAGEN MIMICS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2000-06-14 | — | — | EP | claimed |
| US-5973112-A | Collagen mimics | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1999-10-26 | — | — | US | claimed |
| WO-1999010381-A1 | COLLAGEN MIMICS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1999-03-04 | — | — | WO | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| US-4482725-A | ANGIOTENSIN CONVERTING ENZYME INHIBITOR | E. R. SQUIBB & SONS, INC. (US) | 1984-11-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325672-A1 | ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS | ACE2, SARS1, TMPRSS2 | CYP1A2 3303/4885ALOX15 4068/4885GRM2 2122/4885 |
| US-11904020-B2 | Bicyclic peptide ligands specific for TREM2 | APP, TIMCC, ADM2 | CYP1A2 2389/4885ALOX15 1868/4885GRM2 511/4885 |
| US-20150353619-A1 | Non-Canonical Insulins and Their Uses | IAPP, IDE, INSR | CYP1A2 2895/4885ALOX15 1847/4885GRM2 3617/4885 |
| US-20120035114-A1 | INHIBITORS OF STAT3 AND USES THEREOF | STAT3, JAK2, STAT6 | CYP1A2 4782/4885ALOX15 2409/4885GRM2 4384/4885 |
| US-20260077073-A1 | GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR)-TARGETED COMPOUNDS AND USES THEREOF | GRPR, GIPR, GLP1R | CYP1A2 4724/4885ALOX15 3981/4885GRM2 332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.